In search of the optimal management strategy for Arabian oryx

Extirpated from the wild in 1972 by overhunting, Arabian oryx (Oryx leucoryx) were re-introduced in Saudi Arabia in March 1990; 17 oryx were released into Mahazat as-Sayd, a 2244 km2 fenced reserve in westcentral Arabia, which lies at the periphery of their historical home range. The population has increased to 346 animals. The National Commission for Wildlife Conservation and Development, and those that manage the herd, have recently asked, ‘What is the optimal management strategy to assure long-term persistence of the species, given the absence of immigration and predation?’ Food resources, determinants of rates of mortality and birth, covary with unpredictable rainfall in Mahazat as-Sayd. Using data-driven assumptions, we developed a computer model that evaluated the probability of extinction (Pex) under various management strategies: no intervention, removing a fixed number of animals each year, removing a fixed percentage of animals each year, and removing all individuals above a threshold. In addition, we explored the probability that oryx populations would decline below two thresholds, called the probability of quasi-extinction (Pq-ex) under various management schemes. Our analyses suggested that, without intervention, the oryx population had a high Pex. Removing 15% of the current population provided a low Pex, but this method also produced high values for Pq-ex and, as a by-product, wide fluctuations in population size (N). Although it required an assessment of both N and carrying capacity (K), the most successful management plan consisted of removing all oryx above 70% of K. Adoption of this plan resulted in low Pex, low Pq-ex, and smaller fluctuations in N. Our study may provide a useful model for evaluating management plans for a variety of threatened animal populations in desert ecosystems.Funding for this project was received from the National Wildlife Research Center, Taif, Saudi Arabia, and from the Columbus Zoo, Columbus, OH

Emergence of canine parvovirus subtype 2b (CPV-2b) infections in Australian dogs

Tracing the temporal dynamics of pathogens is crucial for developing strategies to detect and limit disease emergence. Canine parvovirus (CPV-2) is an enteric virus causing morbidity and mortality in dogs around the globe. Previous work in Australia reported that the majority of cases were associated with the CPV-2a subtype, an unexpected finding since CPV-2a was rapidly replaced by another subtype (CPV-2b) in many countries. Using a nine-year dataset of CPV-2 infections from 396 dogs sampled across Australia, we assessed the population dynamics and molecular epidemiology of circulating CPV-2 subtypes. Bayesian phylogenetic Skygrid models and logistic regressions were used to trace the temporal dynamics of CPV-2 infections in dogs sampled from 2007 to 2016. Phylogenetic models indicated that CPV-2a likely emerged in Australia between 1973 and 1988, while CPV-2b likely emerged between 1985 and 1998. Sequences from both subtypes were found in dogs across continental Australia and Tasmania, with no apparent effect of climate variability on subtype occurrence. Both variant subtypes exhibited a classical disease emergence pattern of relatively high rates of evolution during early emergence followed by subsequent decreases in evolutionary rates over time. However, the CPV-2b subtype maintained higher mutation rates than CPV-2a and continued to expand, resulting in an increase in the probability that dogs will carry this subtype over time. Ongoing monitoring programs that provide molecular epidemiology surveillance will be necessary to detect emergence of new variants and make informed recommendations to develop reliable detection and vaccine methods

Data from: Spending limited resources on de-extinction could lead to net biodiversity loss

There is contentious debate surrounding the merits of de-extinction as a biodiversity conservation tool. Here, we use extant analogues to predict conservation actions for potential de-extinction candidate species from New Zealand and the Australian state of New South Wales, and use a prioritization protocol to predict the impacts of reintroducing and maintaining populations of these species on conservation of extant threatened species. Even using the optimistic assumptions that resurrection of species is externally sponsored, and that actions for resurrected species can share costs with extant analogue species, public funding for conservation of resurrected species would lead to fewer extant species that could be conserved, suggesting net biodiversity loss. If full costs of establishment and maintenance for resurrected species populations were publicly funded, there could be substantial sacrifices in extant species conservation. If conservation of resurrected species populations could be fully externally sponsored, there could be benefits to extant threatened species. However, such benefits would be outweighed by opportunity costs, assuming such discretionary money could directly fund conservation of extant species. Potential sacrifices in conservation of extant species should be a crucial consideration in deciding whether to invest in de-extinction or focus our efforts on extant species

NSW dataset and code for prioritization

Code and database for New South Wales prioritization. See ReadMe file for additional details, and see NZ dataset and code ReadMe (http://datadryad.org/resource/doi:10.5061/dryad.3qn55) for details on code design

The relationship between BCMO1 gene variants and macular pigment optical density in persons with and without age-related macular degeneration

Background: Recent evidence indicates that gene variants related to carotenoid metabolism play a role in the uptake of macular pigments lutein (L) and zeaxanthine (Z). Moreover, these pigments are proposed to reduce the risk for advanced age-related macular degeneration (AMD). This study provides the initial examination of the relationship between the gene variants related to carotenoid metabolism, macular pigment optical density (MPOD) and their combined expression in healthy humans and patients with AMD. Participants and Methods: Forty-four participants were enrolled from a general population and a private practice including 20 healthy participants and 24 patients with advanced (neovascular) AMD. Participants were genotyped for the three single nucleotide polymorphisms (SNPs) upstream from BCMO1, rs11645428, rs6420424 and rs6564851 that have been shown to either up or down regulate beta-carotene conversion efficiency in the plasma. MPOD was determined by heterochromatic flicker photometry. Results: Healthy participants with the rs11645428 GG genotype, rs6420424 AA genotype and rs6564851 GG genotype all had on average significantly lower MPOD compared to those with the other genotypes (p < 0.01 for all three comparisons). When combining BCMO1 genotypes reported to have “high” (rs11645428 AA/rs6420424 GG/rs6564851 TT) and “low” (rs11645428 GG/rs6420424 AA/rs6564851 GG) beta-carotene conversion efficiency, we demonstrate clear differences in MPOD values (p<0.01). In patients with AMD there were no significant differences in MPOD for any of the three BCMO1 gene variants. Conclusion: In healthy participants MPOD levels can be related to high and low beta-carotene conversion BCMO1 genotypes. Such relationships were not found in patients with advanced neovascular AMD, indicative of additional processes influencing carotenoid uptake, possibly related to other AMD susceptibility genes. Our findings indicate that specific BCMO1 SNPs should be determined when assessing the effects of carotenoid supplementation on macular pigment and that their expression may be influenced by retinal disease